Detect more quickly the women’s cancers

QMI agency

Wednesday, 21 march, 2018 20:32

UPDATE
Wednesday, 21 march, 2018 20:33

Look at this article

Scientists at the research Centre of McGill University (MUHC) and the John Hopkins University in the United States have jointly developed a new genetic screening test and early cancer of the ovaries and uterus.

Doctors already use a variety of ways to detect women’s cancers as an ultrasound, blood work and the tumor antigen 125, a tumor marker that can be found in the blood. The Pap test has also helped reduce considerably the prevalence of cancer of the cervix.

“For ovarian cancer, develops most often in the fallopian Tubes. The cells and the secretions will flow through the fallopian tube and will arrive in the cavity of the uterus,” explained Dr. Kris Jardon, researcher, gynecologist and oncologist at the MUHC.

The new genetic screening test is done by inserting a small brush through the vagina, into the cervix of the uterus, and the uterine cavity. The doctor then proceeds to smear the inside of the cavity of the uterus with the small brush.

Approximately 1900 women participated in the research, which lasted three years. “It has brought us a diagnosis of 81% to 93% at the level of cancer of the uterus, and from 31 to 45 % at the level of the ovarian cancer,” said Dr. Jardon.

The research will continue, but the Dr. Jardon is hoped that this test will be available in all clinics in Quebec within four years.

Annually, in Canada, there are 7300 new cases of cancer of the endometrium of the uterus and 1200 deaths. It saves 2800 diagnostics of ovarian cancer, and 1800 deaths.